Prolonged QT Interval in Neurodevelopmental Rat Model of Schizophrenia

Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

STRAČINA Tibor RONZHINA Marina ŠTARK Tibor RUDÁ Jana OLŠANSKÁ Eva VESELÝ Petr MICALE Vincenzo NOVÁKOVÁ Marie

Year of publication 2017
Type Article in Proceedings
Conference Computing in Cardiology 2016
MU Faculty or unit

Faculty of Medicine

Citation
Web http://ieeexplore.ieee.org/document/7868926/
Field Physiology
Keywords QT prolongation
Attached files
Description QT prolongation is an independent risk factor for development of ventricular arrhythmias and eventually sudden cardiac death. It is common side effect of various medications, including antipsychotics. It was reported that schizophrenic patients treated with antipsychotics (e.g. haloperidol, olanzapine) manifested QT prolongation. Also, drug-free schizophrenic patients have increased QT interval compared to healthy controls. Possible mechanisms of QT prolongation connected with schizophrenia are still unclear. The present study on isolated hearts clearly shows that rats with schizophrenia-like phenotype manifest significantly lengthened QT interval as compared to controls. This difference was further increased after acute haloperidol administration. These data indicate that methylazoxymethanol acetate rat model of schizophrenia may be applicable tool for studying of connection between schizophrenia and QT prolongation.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info